Article Details
Retrieved on: 2025-02-27 00:20:25
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
Quantum BioPharma completes Phase 1 trial for Lucid-MS in MS patients. Compound deemed safe and well-tolerated. Phase 2 trial next step.
Article found on: investingnews.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here